Our treatment (BDD-NET) is 12 weeks long. This study is open to anyone who is English-speaking regardless of where you live. We are working to make the BDD-NET treatment available globally in the near future.
This clinical trial is being conducted at Karolinska Institutet in Stockholm, Sweden. It has been approved by the Regional Ethical Review Board in Stockholm on February 17, 2016 (D-nr 2016/137-31/4).
In order to maintain safety standards and ensure appropriateness of fit, we require that you meet certain criteria in order to be eligible for this study. To be considered for this study, you must:
- Be at least 18 years of age
- Be preoccupied or worried about possible defects in your appearance
- Be fluent in English
- Have access to a computer with internet capabilities regularly
- Not be diagnosed by a qualified professional with bipolar I or II disorder or a psychotic disorder